| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
8,637 |
7,436 |
$515K |
| 80053 |
Comprehensive metabolic panel |
11,757 |
10,086 |
$248K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,829 |
5,507 |
$241K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,526 |
2,286 |
$220K |
| 87631 |
|
2,724 |
2,609 |
$183K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
845 |
650 |
$136K |
| 99199 |
Unlisted special service, procedure or report |
2,389 |
2,035 |
$126K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,938 |
1,744 |
$123K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,304 |
1,908 |
$113K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,735 |
9,729 |
$107K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,952 |
3,871 |
$92K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,552 |
3,076 |
$84K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,159 |
757 |
$77K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,140 |
704 |
$69K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,441 |
364 |
$67K |
| 83690 |
|
2,759 |
2,316 |
$65K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,846 |
1,501 |
$63K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
5,133 |
4,572 |
$61K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
951 |
784 |
$58K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,034 |
979 |
$55K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,762 |
1,377 |
$53K |
| 80061 |
Lipid panel |
3,253 |
3,217 |
$47K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
577 |
531 |
$37K |
| 71045 |
Radiologic examination, chest; single view |
2,678 |
2,038 |
$35K |
| 84484 |
|
1,976 |
1,653 |
$35K |
| 70450 |
Computed tomography, head or brain; without contrast material |
382 |
271 |
$33K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,428 |
2,395 |
$31K |
| 0250 |
|
3,436 |
2,805 |
$30K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
706 |
679 |
$26K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
706 |
679 |
$26K |
| 81001 |
|
4,501 |
3,954 |
$25K |
| 71046 |
Radiologic examination, chest; 2 views |
1,138 |
934 |
$25K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,197 |
1,045 |
$25K |
| 97139 |
|
893 |
209 |
$22K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,060 |
1,896 |
$19K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
766 |
757 |
$19K |
| 85027 |
|
2,069 |
1,871 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
760 |
663 |
$17K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
359 |
299 |
$16K |
| 86140 |
|
1,417 |
1,239 |
$16K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
119 |
94 |
$15K |
| 83880 |
|
527 |
477 |
$14K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
178 |
151 |
$14K |
| Z7502 |
|
356 |
341 |
$13K |
| 0637 |
|
2,574 |
1,452 |
$11K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,657 |
1,057 |
$11K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
523 |
477 |
$10K |
| 84439 |
|
718 |
694 |
$9K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
112 |
99 |
$9K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
394 |
340 |
$9K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
893 |
596 |
$8K |
| 81025 |
|
702 |
612 |
$8K |
| 85610 |
|
1,732 |
1,462 |
$8K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
173 |
166 |
$8K |
| 83605 |
|
645 |
585 |
$8K |
| 97750 |
|
124 |
83 |
$7K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,216 |
1,033 |
$7K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
232 |
231 |
$7K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
200 |
197 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
183 |
177 |
$7K |
| 84145 |
|
64 |
54 |
$6K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
847 |
705 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,109 |
1,024 |
$6K |
| 97799 |
|
230 |
50 |
$5K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
88 |
78 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
3,969 |
3,602 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
96 |
95 |
$4K |
| 85652 |
|
884 |
817 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
125 |
85 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
117 |
117 |
$3K |
| 82570 |
|
482 |
421 |
$3K |
| 87400 |
|
382 |
370 |
$3K |
| 86318 |
|
116 |
108 |
$2K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
68 |
64 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
107 |
102 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
58 |
55 |
$2K |
| 83735 |
|
232 |
202 |
$2K |
| 86850 |
|
157 |
126 |
$2K |
| 73030 |
|
109 |
80 |
$2K |
| 87430 |
|
114 |
111 |
$2K |
| 0270 |
|
256 |
199 |
$2K |
| 82043 |
|
214 |
214 |
$2K |
| 76830 |
Ultrasound, transvaginal |
27 |
27 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
27 |
26 |
$2K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
52 |
49 |
$1K |
| 87081 |
|
157 |
157 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
33 |
31 |
$1K |
| 85378 |
|
175 |
168 |
$1K |
| 85730 |
|
97 |
94 |
$1K |
| 86803 |
|
164 |
164 |
$1K |
| 86780 |
|
80 |
80 |
$1K |
| 86901 |
|
129 |
125 |
$982.08 |
| 82728 |
|
81 |
80 |
$924.60 |
| 83540 |
|
117 |
117 |
$833.84 |
| 83550 |
|
90 |
90 |
$731.88 |
| 84703 |
|
73 |
70 |
$728.46 |
| 83655 |
|
55 |
55 |
$708.50 |
| 82607 |
|
68 |
68 |
$626.36 |
| 87186 |
|
68 |
63 |
$624.24 |
| 86900 |
|
115 |
112 |
$554.39 |
| 73630 |
|
32 |
25 |
$549.53 |
| 73562 |
|
29 |
25 |
$512.27 |
| 0272 |
|
27 |
24 |
$495.84 |
| 82962 |
|
129 |
99 |
$434.50 |
| 84550 |
|
86 |
65 |
$406.22 |
| Z7610 |
|
32 |
30 |
$405.55 |
| 81003 |
|
144 |
127 |
$402.37 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
57 |
53 |
$401.47 |
| 73130 |
|
15 |
14 |
$332.36 |
| 80299 |
|
12 |
12 |
$318.36 |
| 73610 |
|
13 |
12 |
$283.04 |
| 82746 |
|
12 |
12 |
$245.91 |
| 85018 |
|
81 |
81 |
$222.90 |
| 87340 |
|
26 |
26 |
$221.00 |
| 87040 |
|
39 |
36 |
$195.08 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
13 |
$79.76 |
| 87077 |
|
30 |
27 |
$64.70 |
| 84156 |
|
20 |
12 |
$58.58 |
| 0271 |
|
12 |
12 |
$52.00 |
| J3490 |
Unclassified drugs |
25 |
25 |
$15.03 |
| 85004 |
|
164 |
148 |
$0.00 |